InnovAge Holding Corp. (INNV) Current Ratio
- Current ratio · latest quarter: Value 1.05×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.05× | Current assets / current liabilities. $214.31M ÷ $203.89M ≈ 1.05× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 214.31M USD | Assets, Current |
| Current obligations | 203.89M USD | Liabilities, Current |
| Cash and equivalents | 97.89M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 42.39M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | (m) | |
| Borrowing debt due within one year | 2.54M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $214.31M | $203.89M | $97.89M | (m) | $42.39M | (m) | (m) | $2.54M | 1.05× |
| 2026-03-31 | $202.61M | $195.89M | $95.54M | (m) | $28.58M | (m) | (m) | $2.54M | 1.03× |
| 2025-12-31 | $181.85M | $144.70M | $83.20M | (m) | $21.30M | (m) | (m) | $2.54M | 1.26× |
| 2025-09-30 | $161.70M | $138.49M | $67.15M | (m) | $23.17M | (m) | (m) | $3.00M | 1.17× |
| 2025-06-30 | $176.11M | $164.81M | $64.13M | (m) | $36.37M | (m) | (m) | $2.25M | 1.07× |
| 2025-03-31 | $176.18M | $225.32M | $60.45M | (m) | $44.40M | (m) | (m) | $60.98M | 0.78× |
| 2024-12-31 | $167.95M | $144.97M | $46.08M | (m) | $49.76M | (m) | (m) | $3.79M | 1.16× |
| 2024-09-30 | $158.55M | $131.35M | $39.02M | (m) | $46.73M | (m) | (m) | $3.79M | 1.21× |
| 2024-06-30 | $173.14M | $138.60M | $56.95M | (m) | $48.11M | (m) | (m) | $3.79M | 1.25× |
| 2024-03-31 | $153.07M | $121.97M | $54.09M | (m) | $36.46M | (m) | (m) | $3.79M | 1.25× |
| 2023-12-31 | $156.96M | $123.13M | $54.08M | (m) | $43.46M | (m) | (m) | $3.79M | 1.27× |
| 2023-09-30 | $196.10M | $138.81M | $88.40M | (m) | $44.19M | (m) | (m) | $3.79M | 1.41× |
| 2023-06-30 | $215.23M | $148.45M | $127.25M | (m) | $24.34M | (m) | (m) | $3.79M | 1.45× |
| 2023-03-31 | $215.94M | $137.69M | $121.71M | (m) | $34.20M | (m) | (m) | $3.79M | 1.57× |
| 2022-12-31 | $199.49M | $106.19M | $99.46M | (m) | $38.64M | (m) | (m) | $3.79M | 1.88× |
| 2022-09-30 | $242.93M | $131.41M | $188.22M | (m) | $37.52M | (m) | (m) | $3.79M | 1.85× |
| 2022-06-30 | $240.96M | $105.31M | $184.43M | (m) | $35.91M | (m) | (m) | $3.79M | 2.29× |
| 2022-03-31 | $250.45M | $94.39M | $199.49M | (m) | $31.91M | (m) | (m) | $3.79M | 2.65× |
| 2021-12-31 | $265.94M | $89.32M | $216.31M | (m) | $33.29M | (m) | (m) | $3.79M | 2.98× |
| 2021-09-30 | $260.63M | $81.15M | $215.53M | (m) | $28.39M | (m) | (m) | $3.79M | 3.21× |
| 2021-06-30 | $250.93M | $78.56M | $201.47M | (m) | $32.58M | (m) | (m) | $3.79M | 3.19× |
| 2021-03-31 | $251.88M | $93.98M | $201.53M | (m) | $44.36M | (m) | (m) | $2.85M | 2.68× |
| 2020-06-30 | $166.93M | $76.63M | $112.90M | (m) | $46.31M | (m) | (m) | $1.94M | 2.18× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |